1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Colombia Pharmaceuticals and Healthcare Report Q1 2016

Colombia Pharmaceuticals and Healthcare Report Q1 2016

  • December 2015
  • -
  • Business Monitor International
  • -
  • 90 pages

Includes 3 FREE quarterly updates

BMI View: A growing burden of chronic diseases, along with the Colombian government's push towardimproving health coverage, will ensure the country's retained appeal to multinational drugmakers andhealthcare suppliers. However, high levels of debt among some health insurance providers will fuelinstability in the health care sector.

Headline Expenditure Projections

- Pharmaceuticals: COP8,643bn (USD4.32bn) in 2014 to COP9,101bn (USD3.32bn) in 2015; +5.3% inlocal currency terms.

Forecast broadly unchanged from previous quarter.

- Healthcare: COP51,644bn (USD25.8bn) in 2014 to COP55,502bn (USD20.3bn) in 2015; +7.5% in localcurrency terms. Forecast revised downwards from Q415 due to historical data.

Table Of Contents

Colombia Pharmaceuticals and Healthcare Report Q1 2016
BMI Industry View 7
Table: Headline Pharmaceuticals and Healthcare Forecasts (Colombia 2013-2019) 7
SWOT 9
Industry Forecast 11
Pharmaceutical Market Forecast 11
Table: Pharmaceutical Sales, Historical Data And Forecasts (Colombia 2011-2019) 13
Healthcare Market Forecast 14
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Colombia 2011-2019) 16
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Colombia 2011-2019) 17
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Colombia 2011-2019) 18
Prescription Drug Market Forecast 19
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Colombia 2011-2019) 20
Patented Drug Market Forecast 21
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Colombia 2011-2019) 23
Generic Drug Market Forecast 24
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Colombia 2011-2019) 26
OTC Medicine Market Forecast 27
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Colombia 2011-2019) 29
Pharmaceutical Trade Forecast 30
Table: Pharmaceutical Trade Data And Forecasts (Colombia 2013-2019) 32
Table: Pharmaceutical Trade Data And Forecasts local currency (Colombia 2013-2019) 32
Pharmaceuticals Risk/Reward Index 33
Americas Risk/Reward Index 33
Colombia Risk/Reward Index 40
Rewards 40
Risks 41
Market Overview 42
Market Overview 42
Epidemiology 43
Healthcare Sector 45
Table: Healthcare Resources (Colombia 2009-2014) 49
Table: Healthcare Personnel (Colombia 2009-2014) 49
Table: Healthcare Activity (Colombia 2009-2014) 50
Research And Development 50
Table: Pharmaceutical Research and Science Centre (CECIF) Members, 2015 50
Clinical Trials 51
Regulatory Review 53
Intellectual Property Regime 54
Table: Colombia-US FTA Mechanisms Relevant To Intellectual Property 57
Pricing Regime 57
Reimbursement Regime 59
Competitive Landscape 62
Research-Based Industry 62
Table: Members Of Asociación De Laboratorios Farmaceuticos De Investigación (AFIDRO), 2012 63
Recent Developments 64
Table: Multinational Market Activity 64
Table: Leading Pharmaceutical Companies By Revenues, 2011 (COPmn) 65
Pharmaceutical Distribution 66
Table: Leading Pharmaceutical Importers/Wholesalers By Revenues, 2011 66
Pharmaceutical Retail 67
Company Profile 69
Laboratorios Bussie 69
Laboratorios Genfar SA 72
Lafrancol 75
Demographic Forecast 79
Table: Population Headline Indicators (Colombia 1990-2025) 80
Table: Key Population Ratios (Colombia 1990-2025) 80
Table: Urban/Rural Population and Life Expectancy (Colombia 1990-2025) 81
Table: Population By Age Group (Colombia 1990-2025) 81
Table: Population By Age Group % (Colombia 1990-2025) 82
Glossary 84
Methodology 86
Pharmaceutical Expenditure Forecast Model 86
Healthcare Expenditure Forecast Model 86
Notes On Methodology 87
Risk/Reward Index Methodology 88
Index Overview 89
Table: Pharmaceutical Risk/Reward Index Indicators 89
Indicator Weightings 90

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Prostate Cancer Pricing, Reimbursement, and Access

Prostate Cancer Pricing, Reimbursement, and Access

  • $ 7 500
  • Industry report
  • July 2016
  • by Datamonitor Healthcare

Novel antiandrogens will need to present risk-sharing agreements in EU markets, while discussing contracting with US payers to ensure a competitive advantage. Vaccines suffer from inconclusive response ...

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

  • $ 7 000
  • Industry report
  • August 2016
  • by Frost & Sullivan

Emerging Business Models Drive Transformation The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients ...

IMS World Review Executive™ 2016

IMS World Review Executive™ 2016

  • $ 6 860
  • Industry report
  • July 2016
  • by IMS Health

IMS World Review ExecutiveTM 2016 provides essential insights into worldwide sales of the pharmaceutical market, interlocking market trends and sales analysis from 2011 to 2015, including the breakdown ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.